等待开盘 05-21 09:30:00 美东时间
+0.240
+5.47%
Cingulate (NASDAQ:CING) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of $(0.53) by 79.25 percent. This is a 10.38 percent increase over losses of $(1.06) per share from the
05-14 20:44
Akanda Corp涨22.72%;QuantumScape涨20.25%;联合租赁涨14.35%
04-23 09:01
今日重点评级关注:Ascendiant Capital:维持IGC Pharma"买入"评级,目标价从5美元升至5.25美元;Benchmark:维持Direct Digital Holdings"投机性买入"评级,目标价从2美元升至8美元
04-09 10:15
Wall Street analysts changed outlook on top names. See all changes on Benzinga's analyst ratings page. Price targets and ratings altered for CING, WING, DEFT, FANG, PJT, DOCS, and AMZN.
04-08 21:24
Ascendiant Capital analyst Edward Woo maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $58 to $55.
04-08 17:58
今日重点评级关注:HC Wainwright & Co.:维持Perspective Therapeutics"买入"评级,目标价从12美元升至13美元;Litchfield Hills:维持Star Equity Holdings"买入"评级,目标价从21美元升至28美元
03-24 10:07
Roth Capital analyst Boobalan Pachaiyappan maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $16 to $14.
03-24 01:26
Cingulate slipped in premarket trading as investors weighed its wider quarterly loss against a fresh patent win and new funding to support its ADHD drug launch plans.
03-20 23:28
Gainers Azitra (AMEX:AZTR) stock moved upwards by 87.3% to $0.33 during Friday...
03-20 20:05
Cingulate shares are trading lower after the company reported worse-than-expect...
03-19 00:24